Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis

Version 1 : Received: 20 October 2023 / Approved: 23 October 2023 / Online: 24 October 2023 (07:56:10 CEST)

A peer-reviewed article of this Preprint also exists.

Del Duca, G.; Tavelli, A.; Mastrorosa, I.; Aguglia, C.; Lanini, S.; Brita, A.C.; Gagliardini, R.; Vita, S.; Vergori, A.; Paulicelli, J.; Natalini, G.; D’Urso, A.; Piselli, P.; Gallì, P.; Mondillo, V.; Mastroianni, C.; Tamburrini, E.; Sarmati, L.; Stingone, C.; Lichtner, M.; Nicastri, E.; Farinella, M.; Leserri, F.; Siddu, A.; Maggi, F.; d’Arminio Monforte, A.; Vairo, F.; Barca, A.; Vaia, F.; Girardi, E.; Mazzotta, V.; Antinori, A. Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis. Vaccines 2023, 11, 1761. Del Duca, G.; Tavelli, A.; Mastrorosa, I.; Aguglia, C.; Lanini, S.; Brita, A.C.; Gagliardini, R.; Vita, S.; Vergori, A.; Paulicelli, J.; Natalini, G.; D’Urso, A.; Piselli, P.; Gallì, P.; Mondillo, V.; Mastroianni, C.; Tamburrini, E.; Sarmati, L.; Stingone, C.; Lichtner, M.; Nicastri, E.; Farinella, M.; Leserri, F.; Siddu, A.; Maggi, F.; d’Arminio Monforte, A.; Vairo, F.; Barca, A.; Vaia, F.; Girardi, E.; Mazzotta, V.; Antinori, A. Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis. Vaccines 2023, 11, 1761.

Abstract

Background: we aim to investigate attitudes toward vaccination, by analyzing empirical factors associated with vaccine acceptance in the Lazio region mpox vaccination (MpoxVax) campaign in Italy. Methods: all subjects who accessed to MpoxVax and signed the informed consent were prospectively enrolled in the MPOX-VAC Study and were asked to fill out an anonymous survey. Two endpoints were selected: ‘delayed acceptance’ and ‘early acceptance’, defined as access for vaccination >60 and ≤30 days from the vaccination campaign starting (VCS), respectively. Results: over the study period 1717 individuals underwent vaccination: 129 (7%) >60 [1588 (92.5%) ≤60] and 676 (60%) ≤30 days from VCS. A bisexual orientation, a lower education level and a worse perceived physical and mental health were associated with delayed access to vaccination. Being Pre-Exposure Prophylaxis (PrEP) users and, marginally, HIV positive, having a high perceived risk for mpox infection and reporting high-risk behaviors like the use of recreational drugs/chems, sex under the influence of drugs and/or alcohol and higher number of principal sexual partners, were associated with early access to vaccination. Conclusions: according to our data, risk awareness was a major determinant of early mpox vaccination acceptance. Conversely, worse perceived health status and a low educational level were critical factors associated with delayed vaccination.

Keywords

Mpox infection; mpox vaccination; risk awareness, vaccine acceptance; vaccine hesitancy; health-related quality of life; the Short-Form 36-item questionnaire

Subject

Public Health and Healthcare, Public Health and Health Services

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.